Cas 1425945-79-4,butyl 9-((2,4-dichlorophenyl)amino)thiazolo[5,4-f]quinazoline-2-carbimidate

1425945-79-4

Post Buying Request

Basic information

Product Name: butyl 9-((2,4-dichlorophenyl)amino)thiazolo[5,4-f]quinazoline-2-carbimidate
Synonyms: butyl 9-((2,4-dichlorophenyl)amino)thiazolo[5,4-f]quinazoline-2-carbimidate
CAS NO:1425945-79-4
Molecular Formula:
Molecular Weight: 446.36
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: butyl 9-((2,4-dichlorophenyl)amino)thiazolo[5,4-f]quinazoline-2-carbimidate(CAS DataBase Reference)
NIST Chemistry Reference: butyl 9-((2,4-dichlorophenyl)amino)thiazolo[5,4-f]quinazoline-2-carbimidate(1425945-79-4)
EPA Substance Registry System: butyl 9-((2,4-dichlorophenyl)amino)thiazolo[5,4-f]quinazoline-2-carbimidate(1425945-79-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1425945-79-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1425945-79-4 Suppliers

Recommended suppliers

1425945-79-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1425945-79-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,5,9,4 and 5 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1425945-79:
(9*1)+(8*4)+(7*2)+(6*5)+(5*9)+(4*4)+(3*5)+(2*7)+(1*9)=184
184 % 10 = 4
So 1425945-79-4 is a valid CAS Registry Number.

1425945-79-4Upstream product

1425945-79-4Downstream Products

1425945-79-4Relevant academic research and scientific papers

DYRK1 INHIBITORS AND USES THEREOF

-

Page/Page column 98, (2013/03/26)

The present invention relates to novel thiazolo[5,4-?]quinazoline compounds and methods that are useful in the amelioration, treatment or control of Down's syndrome or early Alzheimer's disease or in the amelioration, treatment or control of cancers, especially solid tumors. More specifically, the invention relates to DYRK1A and/or DYRK1B inhibitors and to methods for preparing such compounds.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1425945-79-4